Back to top

Image: Shutterstock

Top Ranked Value Stocks to Buy for October 22nd

Read MoreHide Full Article

Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 22nd:

Danaos Corporation (DAC - Free Report) : This owner and operator of containerships has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising nearly 14% over the last 60 days.

Danaos Corporation has a price-to-earnings ratio (P/E) of 1.37, compared with 4.40 for the industry. The company possesses a Value Score of A.

Danaos Corporation PE Ratio (TTM)

Danaos Corporation PE Ratio (TTM)

Danaos Corporation pe-ratio-ttm | Danaos Corporation Quote

 

Cowen Inc. (COWN - Free Report) : This investment banking, research, sales and trading, prime brokerage provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 8.3% over the last 60 days.

Cowen Group, Inc. Price and Consensus

Cowen Group, Inc. Price and Consensus

Cowen Group, Inc. price-consensus-chart | Cowen Group, Inc. Quote

 

Cowen has a price-to-earnings ratio (P/E) of 2.65, compared with 16.10 for the industry. The company possesses a Value Score of A.

Cowen Group, Inc. PE Ratio (TTM)

Cowen Group, Inc. PE Ratio (TTM)

Cowen Group, Inc. pe-ratio-ttm | Cowen Group, Inc. Quote

 

Diversified Healthcare Trust (DHC - Free Report) : This medical office and life science properties, senior living communities and wellness centers owner has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 14.3% over the last 60 days.

Diversified Healthcare Trust has a price-to-earnings ratio (P/E) of 4.06, compared with 13.30 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Senior Housing Properties Trust (DHC) - free report >>

Danaos Corporation (DAC) - free report >>

Cowen Group, Inc. (COWN) - free report >>